UGDH Phosphorylation Drives Glycan Synthesis and Enzalutamid
2026-05-25
This study reveals that phosphorylation of UDP-glucose dehydrogenase (UGDH) at serine 316 enhances glycosaminoglycan biosynthesis, tumor cell motility, spheroid growth, and resistance to enzalutamide in prostate cancer models. These findings identify UGDH phosphorylation as a novel regulatory point influencing prostate cancer progression and therapeutic resistance.
Synergistic Meiotic Induction in Mouse SSCs via RA and Nutri
2026-05-24
This study establishes a defined in vitro protocol for inducing meiotic initiation in long-term cultured mouse spermatogonial stem cells by combining retinoic acid with nutrient restriction. The findings provide a mechanistic advance in germ cell biology and offer a robust platform for reproductive and regenerative research.
Amikacin Sulfate: Applied Workflows for Intracellular NTM Re
2026-05-23
Amikacin Sulfate empowers researchers to tackle non-tuberculous mycobacterial infections through targeted delivery and potent bactericidal action, both extracellularly and within host immune cells. This article synthesizes advanced experimental protocols, troubleshooting strategies, and workflow optimizations to maximize data quality and translational impact using APExBIO’s trusted product.
BAPTA-AM: Cell-Permeable Calcium Chelator for Precision Assa
2026-05-22
BAPTA-AM empowers researchers to dissect intricate calcium signaling and apoptosis mechanisms with unmatched precision in live-cell models. Its cell-permeable design, dual channel-blocking action, and robust performance in neuroprotection and arrhythmia regulation make it a versatile asset for experimental biologists.
Necrostatin-1: Potent RIP1 Kinase Inhibitor for Necroptosis
2026-05-22
Necrostatin-1 is a selective RIP1 kinase inhibitor that blocks necroptosis with high potency in cell and animal models. It serves as a benchmark tool for dissecting regulated necrosis pathways and acute injury mechanisms. APExBIO’s product enables reproducible necroptosis assays, supporting translational research in inflammatory and tissue injury models.
Pro-metastatic States Post-Apoptosis: Insights from ER Stres
2026-05-21
Conod et al. (2022) reveal that colon cancer cells surviving near-lethal apoptosis can acquire stable, pro-metastatic states characterized by ER stress, nuclear reprogramming, and a cytokine storm. These findings reframe the understanding of metastasis origin, highlighting the paradoxical risk of inducing prometastatic ecosystems following cell-death-triggering therapies.
Cy3 Rabbit Anti-Goat IgG (H+L) Antibody: Technical Applicati
2026-05-21
The Cy3 Rabbit Anti-Goat IgG (H+L) Antibody enables sensitive and specific detection of goat IgG in fluorescence-based immunoassays such as ICC/IF, IHC, flow cytometry, and ELISA. It should only be used with goat primary antibodies within validated immunodetection workflows, and not for cross-reactive or non-immunoglobulin detection.
Novel 6C Medium Extends Mouse Corneal Epithelial Cell Prolif
2026-05-20
The reference study introduces a serum-free 6C culture medium that significantly prolongs the proliferative activity of mouse corneal epithelial cells (mCEC) in vitro and in vivo. By precisely modulating multiple signaling pathways, including Wnt inhibition via IWP-2, the protocol yields high-quality epithelial progenitors for regenerative applications, offering new avenues for corneal transplantation research.
3-Bromopyruvate Induces Ferroptosis to Overcome Cetuximab Re
2026-05-20
This study demonstrates that co-treatment with 3-bromopyruvate (3-BP) and cetuximab synergistically induces autophagy-dependent ferroptosis in colorectal cancer (CRC) cells with intrinsic or acquired resistance to cetuximab. The findings provide mechanistic insight into overcoming drug resistance in CRC by targeting FOXO3a-mediated pathways.
ω-Agatoxin IVA TFA: Precision Cav2.1 Inhibition in Neurophys
2026-05-19
ω-Agatoxin IVA TFA delivers nanomolar-selective P/Q-type channel blockade, empowering high-fidelity neuronal current recordings and advanced epilepsy model research. This guide translates structural insights and best practices into actionable protocols for synaptic transmission and neuroprotection studies.
Improving In Vitro Drug Response Assessment in Cancer Resear
2026-05-19
This dissertation by Hannah R. Schwartz redefines how in vitro assays evaluate anticancer drug responses, distinguishing between proliferative arrest and cell death. The findings challenge common practices and support the adoption of more nuanced, mechanism-aware methodologies for HDAC inhibitors such as Entinostat (MS-275).
Rifampin: Applied Workflows & Troubleshooting for Transcript
2026-05-18
Rifampin, a rifamycin antibiotic from APExBIO, is a gold standard tool for targeted transcription inhibition in bacterial resistance mechanism research and synthetic biology. This guide delivers actionable workflows, protocol optimizations, and troubleshooting strategies to help researchers achieve consistent, high-fidelity results.
One-step TUNEL FITC Apoptosis Detection Kit: Applied Workflo
2026-05-18
The One-step TUNEL FITC Apoptosis Detection Kit streamlines apoptosis detection in both tissue sections and cultured cells, offering robust sensitivity and workflow efficiency for DNA fragmentation assays. Its validated performance in challenging models, including neurodegeneration and cancer research, enables researchers to confidently quantify apoptosis, troubleshoot pitfalls, and adapt protocols for diverse experimental needs.
Cy3 TSA Fluorescence System Kit: Signal Amplification Unlock
2026-05-17
The Cy3 TSA Fluorescence System Kit empowers researchers to visualize low-abundance targets with unprecedented clarity in immunohistochemistry, immunocytochemistry, and in situ hybridization. Leveraging robust tyramide signal amplification and Cy3’s bright emission, this kit delivers reproducible, ultra-sensitive results for fixed cells and tissues.
Phenothiazines Boost Macrophage Antibacterial Function via R
2026-05-16
This study demonstrates that phenothiazines, a class of dopamine receptor antagonists, markedly enhance the antibacterial activity of macrophages by inducing autophagy and reactive oxygen species (ROS) accumulation. The findings open new avenues for host-directed therapies against intracellular bacterial infections, particularly in the context of antibiotic resistance.
466 records 18/32 page Previous Next First page 上5页 1617181920 下5页 Last page